Regencell Bioscience Holdings Limited Ordinary Shares (RGC) is a publicly traded Healthcare sector company. As of May 21, 2026, RGC trades at $27.56 with a market cap of $13.74B and a P/E ratio of 38.67. RGC moved +3.31% today. Year to date, RGC is +1.29%; over the trailing twelve months it is +131.52%. Its 52-week range spans $0.09 to $83.60. Rallies surfaces RGC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Regencell Bioscience Holdings Limited Ordinary Shares (RGC) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RGC moved +3.31% today.
| Metric | Value |
|---|---|
| Price | $27.56 |
| Market Cap | $13.74B |
| P/E Ratio | 38.67 |
| EPS | $0.72 |
| Dividend Yield | 0.22% |
| 52-Week High | $83.60 |
| 52-Week Low | $0.09 |
| Volume | 40.70K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.16B |
| Net Income | $112.30M |
| Gross Margin | 0.00% |
RGC analyst coverage data. Average price target: $0.00.